Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.

Costs associated with HPV-related diseases such as cervical dysplasia, cervical cancer, and genital warts have not been evaluated in Sweden. These costs must be estimated in order to determine the potential savings if these diseases were eradicated and to assess the combined cost-effectiveness of HP...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Ellinor Östensson, Maria Fröberg, Amy Leval, Ann-Cathrin Hellström, Magnus Bäcklund, Niklas Zethraeus, Sonia Andersson
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Public Library of Science (PLoS) 2015-01-01
Saila:PLoS ONE
Sarrera elektronikoa:http://europepmc.org/articles/PMC4580320?pdf=render